Stockholders’ Equity (Deficit) - Stock-in-lieu of Cash Program Activity (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Shares
Outstanding at beginning of period (in shares) | shares	11,507,643
Outstanding at end of period (in shares) | shares	8,162,850
Weighted Average Grant Date Fair Value per Share
Outstanding as of Beginning Balance | $ / shares	$ 1.72
Outstanding as of Ending Balance | $ / shares	$ 1.74
Vendor stock-in-lieu of cash program
Shares
Outstanding at beginning of period (in shares) | shares	1,500,000
Granted (in shares) | shares	8,824,385
Vested (in shares) | shares	(9,277,234)
Outstanding at end of period (in shares) | shares	1,047,151
Weighted Average Grant Date Fair Value per Share
Outstanding as of Beginning Balance | $ / shares	$ 15.72
Granted (in dollars per share) | $ / shares	9.93
Vested (in dollars per share) | $ / shares	10.65
Outstanding as of Ending Balance | $ / shares	$ 11.90